GARDASIL – Peru, CerviCusco

Access Accelerated
A partnership to administer an HPV vaccination program in Cusco, Peru.
Local NGOs 1
  • To demonstrate the feasibility and acceptability of reaching this population with HPV vaccine and as a model for reaching other similar populations.

MSD* worked with CerviCusco, Direct Relief and the Peru Ministry of Health on an HPV vaccination program in Cusco, Peru. CerviCusco is a clinic for specialized medical care in the prevention and detection of cervical cancer in women from the underserved mountainous region of Cusco. As of early 2018, CerviCusco had nearly completed vaccinating an expected total of over 30,000 persons with GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant].

*MSD is known as Merck & Co., Inc. in the United States & Canada

Geographic Reach
  • Americas
See Where
Disease Area
  • Non-communicable Diseases
  • Vaccine preventable disease
See Disease Areas
Target Population
  • Women
  • Rural populations
SGDs the partnership contributes to
SDG 3: Good Health and Wellbeing
  1. 3.3: Communicable Diseases & NTDs
  2. 3.4: NCDs (including mental health)
  3. 3.8: Achieve universal health coverage
SDG 5: Gender Equality
SDG 10: Reduced Inequalities
SDG 17: Partnerships for the Goals 
Partner organizations
Local NGOs

CerviCusco, with support from Merck and in coordination with the local ministry of health, is responsible for all aspects of program implementation.

Additional information